Dolutegravir and rilpivirine tablets instructions for use

Dolutegravir and rilpivirine tablets instructions for use, for the treatment of adult human immunodeficiency virus type 1 (HIV-1) infection in patients who have achieved virologic suppression (HIV-1 RNA < 50 copies/mL) on a stable antiretroviral treatment regimen for at least six months, have no history of virologic failure, and have no known or suspected resistance to non-nucleoside reverse transcriptase inhibitors or integrase inhibitors.

---